[EN] GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES [FR] INHIBITEURS DE LA GLUCOSYLCÉRAMIDE SYNTHASE POUR LE TRAITEMENT DE MALADIES
[EN] N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS [FR] DÉRIVÉS N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE UTILES EN TANT QU'INHIBITEURS DE LA GLUCOSYLCÉRAMIDE SYNTHASE
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES
申请人:BioMarin Pharmaceutical Inc.
公开号:EP3046920B1
公开(公告)日:2021-08-04
N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
申请人:BioMarin Pharmaceutical Inc.
公开号:EP3063141B1
公开(公告)日:2018-02-28
PIPERIDINE-DIONE DERIVATIVES
申请人:Genentech, Inc.
公开号:US20170001990A1
公开(公告)日:2017-01-05
The invention provides novel compounds having the general formula:
and tautomers and pharmaceutically acceptable salts thereof, wherein A
1
, A
2
, A
3
, A
4
, R
1
, R
4
, R
5
, R
6
, R
7
and R
8
are as defined herein, compositions including the compounds and methods of using the compounds.
[EN] MULTICYCLIC COMPOUNDS AND METHODS OF USING SAME<br/>[FR] COMPOSÉS MULTICYCLIQUES ET LEURS PROCÉDÉS D'UTILISATION
申请人:KARYOPHARM THERAPEUTICS INC
公开号:WO2015042414A1
公开(公告)日:2015-03-26
The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).